Xlife Sciences AG: FUSE-AI, a project company of Xlife Sciences AG enters cooperation agreement with Aarau Cantonal Hospital

DGAP-Media / 25.11.2019 / 07:30

FUSE-AI GmbH, the Hamburg based Artificial Intelligence company, has just entered into a cooperation agreement with the Swiss Cantonal Hospital Aarau. The Aarau Cantonal Hospital will profit from FUSE-AI’s expertise in radiology and artificial intelligence based solutions. These solutions help radiologists diagnose and analyze MRTs. While there is a shortage of skilled workers, there is also a growing number of MRTs, therefore, demand for solutions like these is increasing dramatically. This cooperation with the Aarau Cantonal Hospital represents yet another successful milestone for FUSE-AI and their development.

Xlife Sciences AG

Xlife Sciences AG is a Swiss company with focus on investing in promising technologies in the life science industry. Xlife Sciences AG is building the bridge from research and development to healthcare markets by supporting researchers and entrepreneurs in positioning, structuring, developing and implementing their concepts. Together with industrial partners or universities, Xlife Sciences AG leads projects through the proof-of-concept phase after an invention disclosure or start-up. Subsequently, the firm focuses on out-licensing or selling the company, often with a combination of a strategic partnership. Xlife Sciences AG offers its investors direct access to the further development of innovative and future-oriented technologies at a very early stage.
For more information, please visit: www.xlifesciences.ch

End of Media Release


Issuer: Xlife Sciences AG
Key word(s): Finance

25.11.2019 Dissemination of a Press Release, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Xlife Sciences AG
Klausstrasse 19
8008 Zürich
Switzerland
Phone: 0041 44 385 84 60
E-mail: info@xlifesciences.ch
Internet: www.xlifesciences.ch
ISIN: CH0461929603
Listed: Regulated Unofficial Market in Munich
EQS News ID: 920059

 
End of News DGAP Media

show this